GLANBIA PLC

Glanbia’s latest half‑year results reveal a 30% EPS jump driven by soaring protein demand, diversified product innovation and global expansion, boosting its stock and guiding a higher 2026 outlook.

Glanbia PLC launches a €50 million share buy‑back to boost shareholder value, amid market shifts and its strong nutrition portfolio.

Glanbia PLC’s Q3 2025 earnings hit a 3.3% revenue lift, led by a 14.3% Optimum Nutrition sales jump, prompting an upgraded full‑year guidance that’s boosting shares to a 52‑week high.

Glanbia PLC reported a decline in first-half pretax profit, but raised its full-year earnings guidance and announced a dividend increase, contributing to a positive market response.

Glanbia PLC is a global leader in nutrition, with a diverse range of products and a commitment to innovation and sustainability, positioning it for continued growth and success in the industry.

Glanbia PLC’s stock surged following strong Q1 results, exceeding market expectations and bolstering investor confidence, with the company reaffirming its full-year earnings guidance.

Glanbia PLC’s stock surged following its strong Q1 results, with the company reaffirming its full-year earnings guidance, solidifying investor confidence in its growth potential.

Glanbia PLC’s stock price surged following strong Q1 results, exceeding market expectations and reaffirming the company’s full-year earnings guidance, positioning it for future growth.